Correlation Between Mineralys Therapeutics, and Griffon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Griffon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Griffon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Griffon, you can compare the effects of market volatilities on Mineralys Therapeutics, and Griffon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Griffon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Griffon.

Diversification Opportunities for Mineralys Therapeutics, and Griffon

MineralysGriffonDiversified AwayMineralysGriffonDiversified Away100%
0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Mineralys and Griffon is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Griffon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Griffon and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Griffon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Griffon has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Griffon go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Griffon

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 1.39 times more return on investment than Griffon. However, Mineralys Therapeutics, is 1.39 times more volatile than Griffon. It trades about -0.04 of its potential returns per unit of risk. Griffon is currently generating about -0.1 per unit of risk. If you would invest  997.00  in Mineralys Therapeutics, Common on November 25, 2024 and sell it today you would lose (41.00) from holding Mineralys Therapeutics, Common or give up 4.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Mineralys Therapeutics, Common  vs.  Griffon

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -25-20-15-10-50510
JavaScript chart by amCharts 3.21.15MLYS GFF
       Timeline  
Mineralys Therapeutics, 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb91011121314
Griffon 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Griffon has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb70758085

Mineralys Therapeutics, and Griffon Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-7.46-5.59-3.72-1.84-0.03121.713.485.257.028.79 0.020.040.060.08
JavaScript chart by amCharts 3.21.15MLYS GFF
       Returns  

Pair Trading with Mineralys Therapeutics, and Griffon

The main advantage of trading using opposite Mineralys Therapeutics, and Griffon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Griffon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Griffon will offset losses from the drop in Griffon's long position.
The idea behind Mineralys Therapeutics, Common and Griffon pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk